Source BioScience announced that it has acquired the next-generation sequencing services business from Oxford Gene Technology (OGT) in a move to expand its products and services portfolio. The transfer of business from OGT to Source BioScience is hoped to contribute to the continued success and organic growth of the company.
Nick Ash, CEO of Source BioScience commented in a press statement that the company has forged a strong relationship with OGT and worked together on several projects. Ash said that with this acquisition, customers can now benefit from laboratory services from Source BioScience in conjunction with OGT’s analysis software.
According to Mike Evans, CEO of OGT, the company’s analysis software will be licensed to Source BioScience as part of the transfer, allowing customers continued access to the genetic analysis that OGT provides.
Source: Source BioScience
